Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Probiotic experts Yakult appoints Shinji Yamaguchi as new MD for UK & Ireland, bringing global experience to the fast‑growing gut health category.
-
Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors,...
-
MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation
-
Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors,...
-
PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...
-
PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.
-
ENGLEWOOD, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels and chemicals and carbon management, today announced the appointment of Joan Cetera as...
-
PRESS RELEASE — MARCH 31, 2026 Wendel Appoints Harper Mates as CEO of Wendel North America Wendel today announced a leadership transition for its North American Principal Investing business with...
-
COMMUNIQUÉ — 31.03.2026 Harper Mates est nommée CEO de Wendel North America Dans le cadre de son activité d’investissement pour compte propre, Wendel annonce la nomination de Harper Mates en tant...
-
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO CapitalTetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals,...